Economic Analysis of a Randomized Trial of Academic Detailing Interventions to Improve Use of Antihypertensive Medications

Authors:

Abstract
The authors estimated the costs and cost savings of implementing a program of mailed practice guidelines and single‐visit individual and group academic detailing interventions in a randomized controlled trial to improve the use of antihypertensive medications. Analyses took the perspective of the payer. The total costs of the mailed guideline, group detailing, and individual detailing interventions were estimated at $1000, $5500, and $7200, respectively, corresponding to changes in the average daily per person drug costs of –$0.0558 (95% confidence interval, –$0.1365 to $0.0250) in the individual detailing intervention and –$0.0001 (95% confidence interval, –$0.0803 to $0.0801) in the group detailing intervention, compared with the mailed intervention. For all patients with incident hypertension in the individual detailing arm, the annual total drug cost savings were estimated at $21,711 (95% confidence interval, $53,131 savings to $9709 cost increase). Information on costs of academic detailing could assist with health plan decision making in developing interventions to improve prescribing.

This publication has 18 references indexed in Scilit: